Form 4: Alignment Healthcare Exec Sells Shares

Joseph S. Konowiecki, EVP Corporate Affairs and Director at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.

Summary

• Joseph S. Konowiecki, who holds the positions of EVP, Corporate Affairs and Director at Alignment Healthcare, Inc., has reported a transaction involving the sale of 25,000 shares of common stock.
• The transaction occurred on June 26, 2026, with the shares being sold at a price of $23 per share.
• Following this transaction, Mr. Konowiecki beneficially owns 1,128,816 shares of common stock.
• The sale was made pursuant to a Rule 10b5-1(c) trading plan adopted on March 4, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as slightly negative due to the sale of a significant number of shares by a key executive and director, despite being executed under a pre-arranged trading plan.

Negatives

• An executive officer and director sold a significant number of shares (25,000).

Future Outlook

No specific future outlook or guidance is provided in this filing, as it is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider selling, particularly by executive officers and directors, can sometimes be interpreted by the market as a signal of reduced confidence in the company's future prospects, although sales under Rule 10b5-1 plans are pre-arranged and intended to mitigate such perceptions.

Stakeholder Impact

• Shareholders may view the sale by an executive and director as a potential negative signal, although the Rule 10b5-1 plan is designed to avoid this interpretation.

Key Dates

Recommendation

The sale of shares by a director and executive, even under a Rule 10b5-1 plan, warrants attention. While not necessarily a strong sell signal, it suggests a reduction in direct beneficial ownership by an insider. Without further context on the reasons for the sale or the company's overall performance, a 'hold' recommendation is prudent, advising investors to monitor future insider transactions and company performance.

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Joseph S. Konowiecki, Rule 10b5-1